ANI PHARMACEUTICALS INC

Major Shareholding Notification • Nov 13, 2024

SC 13G/A 1 tm2427812d2_sc13ga.htm SC 13G/A

Field: Rule-Page

Field: /Rule-Page

| SECURITIES
AND EXCHANGE COMMISSION |
| --- |
| Washington,
D.C. 20549 |
| SCHEDULE
13G/A |
| Under
the Securities Exchange Act of 1934 |
| (Amendment
No. 1)* |
| ANI Pharmaceuticals,
Inc. |
| (Name
of Issuer) |
| Common
Stock, $ 0.0001 par value |
| (Title
of Class of Securities) |
| 00182C103 |
| (CUSIP
Number) |
| September 30, 2024 |
| (Date
of event which requires filing of this statement) |
| Check the appropriate
box to designate the rule pursuant to which this Schedule 13G is filed: |
| x Rule 13d-1(b) |
| ¨ Rule 13d-1(c) |
| ¨ Rule 13d-1(d) |
| (Page 1
of 7 Pages) |

Field: Rule-Page

Field: /Rule-Page

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“ Act ”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CUSIP No. 00182C103 13G/A Page 2 of 7 Pages

1	NAMES OF REPORTING PERSONS Rubric Capital Management LP
2	CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ¨ (b) ¨
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 0
	6	SHARED VOTING POWER 56,671 shares of Common Stock
	7	SOLE DISPOSITIVE POWER 0
	8	SHARED DISPOSITIVE POWER 56,671 shares of Common Stock
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 56,671 shares of Common Stock
10	CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.27%
12	TYPE OF REPORTING PERSON PN, IA

Field: Page; Sequence: 2

Field: /Page

CUSIP No. 00182C103 13G/A Page 3 of 7 Pages

1	NAMES OF REPORTING PERSONS David Rosen
2	CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ¨ (b) ¨
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION United States of America
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 0
	6	SHARED VOTING POWER 56,671 shares of Common Stock
	7	SOLE DISPOSITIVE POWER 0
	8	SHARED DISPOSITIVE POWER 56,671 shares of Common Stock
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 56,671 shares of Common Stock
10	CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.27%
12	TYPE OF REPORTING PERSON IN

Field: Page; Sequence: 3

Field: /Page

CUSIP No. 00182C103 13G/A Page 4 of 7 Pages

Item 1(a).
The name of the issuer is ANI Pharmaceuticals, Inc. (the “ Issuer ”).

Item 1(b).
The Issuer’s principal executive offices are located at 210 Main Street West, Baudette, MN, 56623.

Item 2(a).
This statement
is filed by:
(i)	Rubric Capital
Management LP (“ Rubric Capital ”), the investment adviser to certain investment funds and/or accounts (collectively,
the “ Rubric Funds ”) that hold the shares of Common Stock (as defined in Item 2(d) below) reported herein; and
(ii)	David Rosen (“ Mr. Rosen ”),
Managing Member of Rubric Capital Management GP LLC, the general partner of Rubric Capital.
The foregoing persons
are hereinafter sometimes collectively referred to as the “ Reporting Persons .”
The filing of this
statement should not be construed as an admission that any of the forgoing persons or any Reporting Person is, for the purposes of
Section 13 of the Act, the beneficial owner of the Shares reported herein.

Item 2(b).
The address of the principal
business office of each of the Reporting Persons is 155 East 44th St, Suite 1630, New York, NY 10017.

Item 2(c).
Rubric Capital is a
Delaware limited partnership. Mr. Rosen is a citizen of the United States of America.

Item 2(d).
Common Stock, $0.0001 par value (the “ Common Stock ”).

Item 2(e).
00182C103

Field: Page; Sequence: 4

Field: /Page

CUSIP No. 00182C103 13G/A Page 5 of 7 Pages

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

(a)	¨	Broker or dealer registered under Section 15 of the Act,
(b)	¨	Bank as defined in Section 3(a)(6) of
the Act,
(c)	¨	Insurance Company as defined in Section 3(a)(19)
of the Act,
(d)	¨	Investment Company registered under Section 8
of the Investment Company Act of 1940,
(e)	x	An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f)	¨	Employee Benefit Plan or Endowment Fund in accordance
with Rule 13d-1(b)(1)(ii)(F),
(g)	x	Parent Holding Company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G),
(h)	¨	Savings Association as defined in Section 3(b) of
the Federal Deposit Insurance Act,
(i)	¨	A church plan that is excluded from the definition
of an investment company under Section 3(c)(14) of the Investment Company Act;
(j)	¨	A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
(k)	¨	Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: ___________

| Item 4. |
| --- |
| The information required by Items 4(a) - (c) is set forth in Rows
5 - 11 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The percentage set forth in Row (11) of the cover page for each
of the Reporting Persons is based on the 21,030,069 shares of Common Stock outstanding as of July 30, 2024, as reported in the Issuer’s
Quarterly on Form 10-Q for the quarterly period ended June 30, 2024 filed with the Securities and Exchange Commission on August 6,
2024. |

Item 5.
If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial
owner of more than five percent of the class of securities, check the following: x

Item 6.
See Item 2.

Field: Page; Sequence: 5

Field: /Page

CUSIP No. 00182C103 13G/A Page 6 of 7 Pages

Item 7.
Not applicable.

Item 8.
Not applicable.

Item 9.
Not applicable.

ITEM 10. CERTIFICATION.

| Each of the Reporting Persons hereby
makes the following certification: |
| --- |
| By signing below the Reporting Person certifies that,
to the best of its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business
and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer
of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose
or effect. |

Field: Page; Sequence: 6

Field: /Page

CUSIP No. 00182C103 13G/A Page 7 of 7 Pages

SIGNATURES

After reasonable inquiry and to the best of our knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

DATED: November 13, 2024

RUBRIC CAPITAL MANAGEMENT LP
By:	/s/ Michael Nachmani
Name:	Michael Nachmani
Title:	Chief Operating Officer

/s/ David Rosen
DAVID ROSEN

Field: Page; Sequence: 7; Options: Last

Field: /Page